getinge overview l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Getinge overview PowerPoint Presentation
Download Presentation
Getinge overview

Loading in 2 Seconds...

play fullscreen
1 / 35

Getinge overview - PowerPoint PPT Presentation


  • 461 Views
  • Uploaded on

Getinge overview . An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly and disabled people Customers Acute care Long term care Industry / Laboratories Net Sales 8.6 billion SEK Associates 5 600

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Getinge overview' - ivanbritt


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
getinge overview
Getinge overview

An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly and disabled people

Customers Acute care Long term care Industry / Laboratories

Net Sales 8.6 billion SEK

Associates 5 600

Manufacturing 18 production units in 9 countries

Distribution 70 sales companies in 25 countries Distributors in 100 countries

(ex Jostra and LSS)

business scope

B u s i n e s s A r e a s

Infection Control40%

Extended Care31 %

Surgical Systems

29 %

Industry I0 %

Acute Care 60 %

Long Term Care 30 %

C u s t o m e r S e g m e n t s

(ex Jostra and LSS)

Business Scope
slide4

Getinge Group Objectives

  • Strategic
  • To develop world leading positions in prioritized
  • niches of the health care industry
slide5

Strong Global Positions

Business unit

Position

Market shares

BA Infection Control Sterilization # 1 24 %

Disinfection # 1 27 %

BA Surgical Systems Surgical Tables # 1 40 %

Surgical Lights # 1 38 %

Ventilators # 1 28 %

Cardiopulmonary # 3 22 %

Ceiling Service Units # 3 15 %

Anaesthesia # 3 6 %

BA Extended Care Hygiene Systems # 1 60 %

Patient Handling # 1 40 %

Wound Care # 4 5 %

slide6

Getinge Group Objectives

  • Strategic
  • To develop world leading positions in prioritized
  • niches of the health care industry
  • Financial
  • To increase profit before tax with an average of I5%
  • per annum
  • Internally generated cash flow to sustain an external
  • growth rate of I0% per annum
slide7

The Getinge Group

10000

1000

9000

8000

800

7000

6000

600

5000

4000

400

3000

2000

200

1000

CAGR 24 %

0

0

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

Invoiced sales

Profit before tax

slide8

The Getinge Group - Focus & Development

Infection Control

Improved Operating Performance

ExtendedCare

Organic Growth

SurgicalSystems

External Growth

infection control
Infection Control

Create a customer focused group from a number of companies acquired over the last 10 years

infection control11

1990 - 2000

2000 - 2002

2003 

Growth through acquisition

Business development

Restructuring

- Improve production structure- Organisational focus

- Brand identity

- Organic growth- Product development

- Integrated solutions

- Logistics / distribution

- Service provider concept

INFECTION CONTROL
extended care
Extended Care

Focus on growth from a solid platform through product innovation, market penetration and geographical expansion

highlights 2003
HIGHLIGHTS 2003

GROWTH

  • Market penetration
  • Strong product pipeline
  • Geographical expansion

COMPETITIVENESS

  • Global sourcing
  • Improved productionstructure
  • Improved logistics
surgical systems
Surgical Systems

Create a global leader in the field of Surgical workstations as a platform for further growth in the surgical systems market

surgical workstations
SURGICAL WORKSTATIONS
  • Growth opportunities
    • Japan and USA
  • Product development
    • AWIGS / VIWAS
    • New Pendant generation
    • New Light technology
  • Cross selling
  • Heraeus integration
external growth surgical systems

Radiology

Disposables

Patient monitoring

Surgical instruments

Life Support

Ancillary Equipment

EXTERNAL GROWTH Surgical Systems
slide23

Jostra in brief

  • Sales approx 90 M EUR in 2002
  • Associates ~ 600
  • Sales in 100 countries, own sales companies in:
  • DE, FR, IT, JP, CA, ES, GB, NL, SE, CN, HK
  • Production: Germany (2 sites), Sweden and Denmark
  • Products: Heart-lung machines, Oxygenators, Centrifugal pumps, related Disposables, Minimal Invasive on-pump Equipment
  • Excellent technology and product pipeline, 55 issued patents
  • Good track record of organic growth 10% +
slide24

Jostra Integration and Restructuring

  • New management team from 1st August 2003
  • Integration of Jostra’s sales and marketing
  • organisation with that of Surgical Systems
  • Consolidation of Jostra production structure from 4 to
  • 2 sites
  • Reinforce sales and marketing organisation to drive
  • market penetration in Europe and emerging markets
  • Focus the R&D pipeline to deliver new technologies in
  • a speedy and timely manner
slide25

Jostra Acquisition Financials

  • The target is to improve Jostra’s EBIT margin to
  • 12 - 15% within 3 years after goodwill amortization
  • Contribution to group earnings in 2003 will be
  • slightly negative to neutral
  • Contribution to group pre-tax profit including
  • goodwill amortization and related financial charges
  • will be in the range of EUR 5 - 6 million in 2004
slide27

Sales of 175 MEUR

Global marketshares 27%

Sales of 30 MEUR

Global marketshares 6%

Key Data of LSS

Life Support Systems (LSS)

LSS is one of the world’s leading providers of ventilation and anaesthesia products in the critical care equipment market

In 2002/03, LSS have projected revenues of around 205 MEUR

The worldwide ventilation and anaesthesia hospital markets account for approx 550 MEUR annual sales volume each, with an expected annual growth of approx. 5% p.a.

LSS-Ventilation

LSS-Anaesthesia

slide29

Financials

LSS will contribute with 10 - 12 MEUR to pretax profit in fiscal 2004

LSS will contribute with 17 - 20 MEUR to pretax profit in fiscal 2005

Operating margins after goodwill depreciation is targeted at 15% longterm